Drugs / MR1817
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00960180 | Jul 2010 → Jan 2011 | — | Mochida Pharmaceutical Company, Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MR1817 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00960180 ↗ |
| Action | Inhibit | “Vanilloid receptor antagonist” CHEMBL3707397 ↗ |
| Route | Oral | “after administration of ascending single oral doses to healthy adult subjects” NCT00960180 ↗ |
| Target | TRPV1 | “Vanilloid receptor antagonist” CHEMBL3707397 ↗ |